Aidoc granted AI ‘industry-first’ FDA clearance for triage of incidental pulmonary embolism
This marks the company’s sixth FDA clearance, paves the way for the commercial use of its triaging and notification algorithms
The cleared solution provides an ‘always-on’ safety net for unexpected cases, now available alongside five other FDA-approved tools for triage and notification: Intracranial Hemorrhage, C-Spine Fractures, Large Vessel Occlusion, Intra Abdominal Free Gas, and Pulmonary Embolism on dedicated exams.
“The most common use case we experienced is for critical unsuspected findings in oncology surveillance patients” added Dr. Cindy Kallman, Chief, Section of CT at Cedars-Sinai Medical Center. “The ability to call the referring physician while the patient is still in the house is huge. We are essentially offering a point-of-care diagnosis of PE for our outpatients, with almost no extra effort. Our referring physicians have been completely wowed by this.”
Aidoc was founded in 2016 by Elad Walach, Guy Reiner, and Michael Braginsky. It provides artificial intelligence tools to assist radiologists by detecting and pinpointing abnormalities with deep learning and AI algorithms that analyze medical images. In September, it raised $20 million in series B bringing its total funding to $60 million.